Agency: NIH/NIMH
Agency Award Number: R01MH058076
To evaluate the efficacy of a CNS-targeted antiretroviral treatment (ART) strategy for individuals with HIV-associated neurocognitive impairment (HNCI) through a randomized clinical trial.
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-targeted HAARTAgency: NIH/NIMH To evaluate the efficacy of a CNS-targeted antiretroviral treatment (ART) strategy for individuals with HIV-associated neurocognitive impairment (HNCI) through a randomized clinical trial. |
Speaking Out to Support HIV+ WomenKFMB-TV CBS8 - San Diego (March 10, 2011) |